Guardant Health
GH
#1616
Rank
NZ$22.00 B
Marketcap
NZ$169.44
Share price
-2.12%
Change (1 day)
175.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company